SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 145 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,767 | -66.1% | 1,201 | -61.5% | 0.00% | -66.7% |
| Q2 2023 | $81,858 | +166957.1% | 3,122 | +64.3% | 0.00% | +50.0% |
| Q1 2023 | $49 | -83.1% | 1,900 | -83.0% | 0.00% | -83.3% |
| Q4 2022 | $290 | -99.6% | 11,146 | +330.3% | 0.01% | +1100.0% |
| Q3 2022 | $74,000 | -78.6% | 2,590 | -81.6% | 0.00% | -87.5% |
| Q2 2022 | $346,000 | -0.3% | 14,083 | +128.7% | 0.01% | +166.7% |
| Q1 2022 | $347,000 | -0.6% | 6,158 | +9.3% | 0.00% | -50.0% |
| Q4 2021 | $349,000 | +47.3% | 5,633 | +50.9% | 0.01% | 0.0% |
| Q3 2021 | $237,000 | -35.6% | 3,732 | -16.3% | 0.01% | -40.0% |
| Q2 2021 | $368,000 | +503.3% | 4,458 | +437.1% | 0.01% | +900.0% |
| Q1 2021 | $61,000 | -11.6% | 830 | -12.8% | 0.00% | -50.0% |
| Q4 2020 | $69,000 | -86.6% | 952 | -91.2% | 0.00% | -66.7% |
| Q3 2020 | $516,000 | +416.0% | 10,815 | +356.3% | 0.01% | +50.0% |
| Q2 2020 | $100,000 | +354.5% | 2,370 | +133.7% | 0.00% | +100.0% |
| Q3 2019 | $22,000 | – | 1,014 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
| Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
| M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
| Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
| Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
| EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
| Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
| Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
| Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |